Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RD07 / Nanjing Bioheng Biotech
ChiCTR2100052903: A clinical study on the safety and effectiveness of RD07 cell injection in the treatment of patients with advanced Claudin 18.2 positive solid tumors	Not yet recruiting	1	18		RD07 cell injection	Zhongshan Hospital Affiliated to Fudan University; Zhongshan Hospital Affiliated to Fudan University, Nanjing Bioheng Biotech Co.，Ltd	solid tumor
ChiCTR2200056008: Clinical study on the safety and efficacy of RD07 cell injection in the treatment of patients with advanced Claudin 18.2 positive solid tumors	Recruiting	1	36		Cell injection	Beijing Cancer Hospital; Level of the institution：, Nanjing Bioheng Biotech Co.，Ltd	solid tumor
ChiCTR2000038650: RD07 in Patients With Advanced Claudin18.2+ Solid Tumors	Not yet recruiting	N/A	18		Treatment by RD07 cell infusion	The First Affiliated Hospital of Zhengzhou University; The First Affiliated Hospital of Zhengzhou University, Nanjing Bioheng Biotech Co., Ltd.	Advanced Claudin18.2+ Solid Tumors
ChiCTR2100044336: A phase I/II clinical study of the safety and preliminary efficacy of RD07 cell injection in patients with advanced Claudin 18.2-positive solid tumor	Not yet recruiting	N/A	36		RD07 cell injection	Jiangsu Cancer Hospital; Jiangsu Cancer Hospital, Nanjing Bioheng Biotech Co.，Ltd	solid tumor